Lantheus Medical Imaging
Lantheus Medical Imaging Initiates CaRES Registry to Further Evaluate DEFINITY in Patients with Suboptimal Echocardiograms
Published in Medical Letter on the CDC and FDA, May 25th, 2008
Lantheus Medical Imaging, a worldwide leader in diagnostic imaging, announces the initiation of CaRES (Contrast Echocardiography REgistry for Safety Surveillance), a multi-center Phase IV observational study that will further evaluate the safety profile of DEFINITY(R) Vial For (Perflutren Lipid Microsphere) Injectable Suspension in patients with suboptimal echocardiograms and provide safety information on the use of ultrasound contrast agents in routine clinical practice.
The open-label, non-randomized registry will be conducted in at least 10 clinical sites in the United States and include at least 1,600 patients. The study will gather data on patient characteristics...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Society for General Microbiology
Scientists discover why plague is so lethal - Alzheimer Disease
Studies from University of Washington in the area of Alzheimer disease described - Drug Development
Study data from University of Rochester update knowledge of drug development - Life Sciences
Research results from K.C. Wood and co-authors update knowledge of life sciences - Life Sciences
Researchers from Food & Drug Administration discuss findings in life sciences - Smoking
New Evidence Provides Clinicians With Better Tools to Help Smokers Quit - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
